Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3528361015 | PCSK9 inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 3528362010 | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3528363017 | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Is a | Substance with hydrolase inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Has disposition | Proprotein convertase subtilisin/kexin type 9 inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Is a | Substance with enzyme inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Is a | Drug or medicament | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Alirocumab | Is a | True | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Evolocumab | Is a | True | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Product containing proprotein convertase subtilisin/kexin type 9 inhibitor (product) | Has active ingredient | True | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | 1 |
| Inclisiran | Is a | True | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Adverse reaction to proprotein convertase subtilisin/kexin type 9 inhibitor | Causative agent | True | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | 1 |
| Allergy to proprotein convertase subtilisin/kexin type 9 inhibitor | Causative agent | True | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets